Skip to content

Based on my analysis of the GO-CAM model and the relevant literature, here is my comprehensive review:

Review of GO-CAM Model: PIV5-V Inhibition of STAT1 via DDB1/CUL4A (Human-Paramyxovirus)

Model ID: gomodel:62f58d8800001316

Overview

This GO-CAM model represents the molecular mechanism by which the V protein of Parainfluenza virus 5 (PIV5) inhibits STAT1 function through a DDB1/CUL4A-mediated ubiquitination pathway. The model illustrates how viral proteins can hijack host cellular machinery to suppress interferon-mediated immune responses.

Model Components

The model includes the following key molecular activities:

  1. DDB1 (UniProtKB:Q16531) - Performs cullin family protein binding activity (GO:0097602)
  2. CUL4A (UniProtKB:Q13619) - Performs ubiquitin protein ligase binding (GO:0031625)
  3. RBX1 (UniProtKB:P62877) - Performs ubiquitin protein ligase activity (GO:0061630)
  4. PIV5-V protein (UniProtKB:P11207) - Performs ubiquitin-like ligase-substrate adaptor activity (GO:1990756)
  5. STAT1 (UniProtKB:P42224) - Performs DNA-binding transcription factor activity (GO:0000981)

Pathway Logic and Causal Flow

The model correctly represents the causal flow of the mechanism:

  1. PIV5-V protein acts as an adaptor for substrate recognition in the ubiquitin ligase complex
  2. DDB1 functions as a scaffold component that positively regulates RBX1
  3. CUL4A positively regulates RBX1's ubiquitin ligase activity
  4. RBX1 directly negatively regulates STAT1
  5. STAT1 is localized to the nucleus (GO:0005634) and functions in the type I interferon-mediated signaling pathway (GO:0060337)

This causal flow correctly represents how the virus-encoded V protein hijacks the host cullin-RING ubiquitin ligase complex to target STAT1 for degradation, thereby suppressing interferon-mediated antiviral responses.

Biological Accuracy

The model accurately represents the established biological mechanism based on the cited literature. Key references such as PMID:16051811 describe how Paramyxovirus V proteins assemble STAT-specific ubiquitin ligase complexes from cellular components to target STAT proteins for degradation.

The relationships between PIV5-V, DDB1, CUL4A, and the targeting of STAT1 are well-supported by the literature. PMID:16482215 and PMID:20870715 provide evidence for the role of these components in the ubiquitin-mediated proteolysis pathway.

Adherence to GO-CAM Best Practices

The model follows GO-CAM best practices in several aspects:

  1. Activities and molecular functions: Each protein is associated with an appropriate molecular function term.
  2. Cellular context: STAT1 is correctly annotated as occurring in the nucleus (GO:0005634).
  3. Biological processes: Activities are appropriately nested within relevant biological processes.
  4. Causal relationships: The model uses appropriate causal relationship predicates (RO:0002629 for "directly positively regulates" and RO:0002630 for "directly negatively regulates").
  5. Evidence codes: The model includes appropriate evidence codes (ECO:0000314 for direct assay evidence) and PMIDs as references.

Recommendations for Improvement

While the model is generally well-constructed, I suggest the following improvements:

  1. STAT1 activity detail: The model could benefit from more detail about STAT1's specific gene targets in the interferon response pathway. The current representation shows STAT1's DNA-binding transcription factor activity but doesn't specify which genes it regulates.

  2. Additional biological context: The model could be enhanced by including information about how STAT1 degradation specifically impairs interferon signaling. This could include downstream consequences such as inhibition of antiviral gene expression.

  3. Temporal aspects: The model could potentially include information about when during viral infection this mechanism is activated. This temporal context would provide additional biological insight.

  4. Subcellular localization: While STAT1 is correctly annotated as occurring in the nucleus, adding subcellular localization information for other components of the pathway would improve the model's completeness.

  5. Complementary immune evasion mechanisms: If applicable, the model could reference other immune evasion mechanisms employed by paramyxoviruses that work in conjunction with STAT1 degradation.

Conclusion

This GO-CAM model (gomodel:62f58d8800001316) effectively represents the molecular mechanism by which the PIV5-V protein inhibits STAT1 function through DDB1/CUL4A-mediated ubiquitination. The model adheres to GO-CAM best practices and accurately reflects the current biological understanding as supported by the literature. With the suggested improvements, the model could provide an even more comprehensive representation of this virus-host interaction pathway.

The model represents an important immune evasion mechanism employed by paramyxoviruses to suppress interferon-mediated antiviral responses, making it a valuable resource for understanding virus-host interactions.